Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Standaert

Showing results (21-30 of 188) with videos related to

Pageof 19
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|August 9, 2016
SNPing SCNA regulatory elements gives a CRISPR view of genetic susceptibility in Parkinson's diseaseDavid A Figge, David G Standaert
Biochimica Et Biophysica Acta|October 22, 2008
Targets for neuroprotection in Parkinson's diseaseTalene A Yacoubian, David G Standaert
Pharmacology & Therapeutics|May 28, 2004
Rationale for and use of NMDA receptor antagonists in Parkinson's diseasePenelope J Hallett, David G Standaert
Movement Disorders Clinical Practice|November 9, 2020
Brain Alchemy: Transforming Astrocytes into Neurons for Neurodegenerative DiseaseGregory P Williams, David G Standaert
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2022
Alpha-synuclein-mediated DNA damage, STING activation, and neuroinflammation in Parkinson's diseaseDavid G Standaert, Gabrielle M Childers
Movement Disorders : Official Journal of the Movement Disorder Society|January 8, 2014
Reaping what you sow: Cross-seeding between aggregation-prone proteins in neurodegenerationTalene A Yacoubian, David G Standaert
Journal of Neurochemistry|May 21, 2013
Removing the blinkers: moving beyond striatal dopamine in Parkinson's diseaseKaren L Eskow Jaunarajs, David G Standaert
Molecular Neurodegeneration|October 28, 2010
Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's diseaseShuwen Cao, Shaji Theodore, David G Standaert
Journal of Parkinson'S Disease|January 16, 2015
Role of α-synuclein in inducing innate and adaptive immunity in Parkinson diseaseHeather E Allen Reish, David G Standaert
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2016
Invisible KillersLaura A Volpicelli-Daley, David G Standaert
Pageof 19

Showing results (21-30 of 188) with videos related to

Sort By:
Pageof 19
Movement Disorders : Official Journal of the Movement Disorder Society|August 9, 2016
SNPing SCNA regulatory elements gives a CRISPR view of genetic susceptibility in Parkinson's diseaseDavid A Figge, David G Standaert
Biochimica Et Biophysica Acta|October 22, 2008
Targets for neuroprotection in Parkinson's diseaseTalene A Yacoubian, David G Standaert
Pharmacology & Therapeutics|May 28, 2004
Rationale for and use of NMDA receptor antagonists in Parkinson's diseasePenelope J Hallett, David G Standaert
Movement Disorders Clinical Practice|November 9, 2020
Brain Alchemy: Transforming Astrocytes into Neurons for Neurodegenerative DiseaseGregory P Williams, David G Standaert
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2022
Alpha-synuclein-mediated DNA damage, STING activation, and neuroinflammation in Parkinson's diseaseDavid G Standaert, Gabrielle M Childers
Movement Disorders : Official Journal of the Movement Disorder Society|January 8, 2014
Reaping what you sow: Cross-seeding between aggregation-prone proteins in neurodegenerationTalene A Yacoubian, David G Standaert
Journal of Neurochemistry|May 21, 2013
Removing the blinkers: moving beyond striatal dopamine in Parkinson's diseaseKaren L Eskow Jaunarajs, David G Standaert
Molecular Neurodegeneration|October 28, 2010
Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's diseaseShuwen Cao, Shaji Theodore, David G Standaert
Journal of Parkinson'S Disease|January 16, 2015
Role of α-synuclein in inducing innate and adaptive immunity in Parkinson diseaseHeather E Allen Reish, David G Standaert
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2016
Invisible KillersLaura A Volpicelli-Daley, David G Standaert
Pageof 19